IMA (ImageneBio) PEG Ratio: N/A (As of Jul. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IMA ImageneBio Inc IMA
10 GF Score
Price $5.59
! 3 Warning Signs
View Full Analysis

What is ImageneBio PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, ImageneBio's PE Ratio without NRI is 0.00. ImageneBio's 5-Year EBITDA growth rate is 0.00%. Therefore, ImageneBio's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for ImageneBio's PEG Ratio or its related term are showing as below:



IMA's PEG Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 1.92
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


ImageneBio  (NAS:IMA) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


ImageneBio PEG Ratio Related Terms


ImageneBio PEG Ratio Historical Data

* Premium members only.

The historical data trend for ImageneBio's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ImageneBio PEG Ratio Chart

ImageneBio Annual Data
Trend Dec23 Dec24 Dec25
PEG Ratio
0.00 0.00 0.00

ImageneBio Quarterly Data
Dec23 Sep24 Dec24 Mar25 Sep25 Dec25 Mar26
PEG Ratio Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

IMA vs HYFT, CING, CRDF: PEG Ratio Comparison

For the Biotechnology subindustry, ImageneBio's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ImageneBio PEG Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ImageneBio's PEG Ratio distribution charts can be found below:

* The bar in red indicates where ImageneBio's PEG Ratio falls into.


IMA
10GF Score
ImageneBio Inc IMA
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ImageneBio PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

ImageneBio's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


ImageneBio Business Description

Address 12526 High Bluff Drive, Suite 345, San Diego, CA, USA, 92130
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.
10GF Score

Get the complete analysis for IMA

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.59
Price